Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Pediatric Hepatobiliary Diseases and Treatments, and Liver physiology and pathology.
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world
87P Clinical characteristics and outcomes of patients with cholangiocarcinoma (CCA) undergoing liver transplantation (LT): An observational study from the ENSCCA registry
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives
Biliary drainage in patients with malignant distal biliary obstruction: results of an Italian consensus conference
Biliary drainage in patients with malignant distal biliary obstruction: results of an Italian consensus conference.
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large real-world cohorts
ASO Visual Abstract: Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease
Impact on follow-up strategies in patients with primary sclerosing cholangitis.
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
Impact on follow‐up strategies in patients with primary sclerosing cholangitis
Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid
Machine learning in primary biliary cholangitis: A novel approach for risk stratification.
Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasis.
Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasis
Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581].
Predictors of Serious Adverse Event and Non-response in Cirrhotic Patients With Primary Biliary Cholangitis under Obeticholic Acid
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
Real-world experience with obeticholic acid in patients with primary biliary cholangitis
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut‐Off Approach
Real-world experience with obeticholic acid in patients with primary biliary cholangitis.